Finance

Lists
1J5:SGX
Hyphens Pharma International Ltd
SGD 0,37
+1,37%
(+0,0050) 1D
16 Okt., 12:58:51 GMT+8  ·   SGD
All symbols
SymbolPriceChange% Change
Generating top insights for 1J5...
Open
SGD 0,37
High
SGD 0,37
Low
SGD 0,37
Mkt. cap
114,40 m
Avg. vol.
64,43 k
Volume
400,00
Dividend
4,05%
Quarterly dividend
SGD 0,00
Ex-dividend date
08 Mei 2024
P/E ratio
13,48
52-wk high
SGD 0,38
52-wk low
SGD 0,30
EPS
SGD 0,03
Shares outstanding
309,20 m
No. of employees
465
Open
SGD 0,37
High
SGD 0,37
Low
SGD 0,37
Mkt. cap
114,40 m
Avg. vol.
64,43 k
Volume
400,00
Dividend
4,05%
Quarterly dividend
SGD 0,00
Ex-dividend date
08 Mei 2024
P/E ratio
13,48
52-wk high
SGD 0,38
52-wk low
SGD 0,30
EPS
SGD 0,03
Shares outstanding
309,20 m
No. of employees
465
News stories
From web sources and news partners
About Hyphens Pharma International Ltd
CEOLim See Wah
Employees465
Founded1998
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in SGD
Loading Previous Earnings...
Revenue
Net income
All values in SGD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
43,91 m
43,91 m
44,53 m
44,53 m
Cost of goods sold
26,08 m
26,08 m
26,06 m
26,06 m
Cost of revenue
26,08 m
26,08 m
26,06 m
26,06 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14,34 m
14,34 m
14,96 m
14,96 m
Operating expense
14,34 m
14,34 m
14,96 m
14,96 m
Total operating expenses
40,42 m
40,42 m
41,03 m
41,03 m
Operating income
3,49 m
3,49 m
3,51 m
3,51 m
Other non operating income
-391,00 k
-391,00 k
89,50 k
89,50 k
EBT including unusual items
2,59 m
2,59 m
3,17 m
3,17 m
EBT excluding unusual items
2,63 m
2,63 m
3,17 m
3,17 m
Income tax expense
519,50 k
519,50 k
868,00 k
868,00 k
Effective tax rate
20,07%
20,07%
27,39%
27,39%
Other operating expenses
-
-
-
-
Net income
2,08 m
2,08 m
2,18 m
2,18 m
Net profit margin
4,74%
4,74%
4,89%
4,89%
Earnings per share
-
-
-
-
Interest and investment income
27,50 k
27,50 k
-
-
Interest expense
-110,50 k
-110,50 k
-90,50 k
-90,50 k
Net interest expenses
-83,00 k
-83,00 k
-90,50 k
-90,50 k
Depreciation and amortization charges
-
-
-
-
EBITDA
3,61 m
3,61 m
4,29 m
4,29 m
Gain or loss from assets sale
44,00 k
44,00 k
32,50 k
32,50 k
AI content may include mistakes. Learn more
Google-programme